<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1597230</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2025.1597230</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanisms of natural killer cell-mediated clearance of senescent renal tubular epithelial cells</article-title>
<alt-title alt-title-type="left-running-head">Funk et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1597230">10.3389/fcell.2025.1597230</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Funk</surname>
<given-names>Nils David</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3068201/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sinning</surname>
<given-names>Julius</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3033167/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaser</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soerensen-Zender</surname>
<given-names>Inga</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wulfmeyer</surname>
<given-names>Vera Christine</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmidt-Ott</surname>
<given-names>Kai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brand</surname>
<given-names>Korbinian</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2559789/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Halle</surname>
<given-names>Stephan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1634665/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Schmitt</surname>
<given-names>Roland</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/941376/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Nephrology and Hypertension</institution>, <institution>Hannover Medical School</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Clinical Chemistry and Laboratory Medicine</institution>, <institution>Hannover Medical School</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Immunology</institution>, <institution>Hannover Medical School</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Nephrology and Hypertension</institution>, <institution>University Hospital Schleswig-Holstein</institution>, <addr-line>Kiel</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/441378/overview">Jianjun Zhou</ext-link>, Tongji University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1433068/overview">Chengang Xiang</ext-link>, Peking University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2807082/overview">Liqun Huang</ext-link>, Tongji University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3020771/overview">Xuelei Wang</ext-link>, Shanghai Jiao Tong University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Stephan Halle, <email>Halle.Stephan@MH-Hannover.de</email>; Roland Schmitt, <email>Roland.Schmitt@uksh.de</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1597230</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Funk, Sinning, Schaser, Soerensen-Zender, Wulfmeyer, Schmidt-Ott, Brand, Halle and Schmitt.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Funk, Sinning, Schaser, Soerensen-Zender, Wulfmeyer, Schmidt-Ott, Brand, Halle and Schmitt</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Intact kidney function is essential for fluid and electrolyte homeostasis, with renal tubular epithelial cells providing critical functions in the reabsorption or secretion of numerous metabolites. Cellular senescence of the renal epithelial cells can lead to functional deficits. Therefore, immune-cell-mediated clearance of senescent epithelial cells can be an important factor for the maintenance of kidney function.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this study, we established a model to directly monitor natural killer (NK) cell-mediated clearance of senescent renal tubular cells. To this end we used primary cell co-cultures with different read-outs and life cell imaging.</p>
</sec>
<sec>
<title>Results and Discussion</title>
<p>We observed that the clustering of NK cells on senescent renal epithelial cells could be used to detect senescence-triggered NK cell activation. Also, we found that NKG2D signaling and perforin-dependent lysis of senescent renal epithelial cells were crucial steps in the lysis of senescent cells. In addition, NK cell-mediated attack of senescent renal epithelial cells could be dampened by the addition of cyclosporine A and was augmented by the addition of interleukin 7. Together, these data show that NK cells can efficiently mediate the clearance of senescent renal tubular epithelial cells involving NK cell activation by NKG2D signaling.</p>
</sec>
</abstract>
<kwd-group>
<kwd>senescence</kwd>
<kwd>NK cells</kwd>
<kwd>kidney</kwd>
<kwd>PTEC</kwd>
<kwd>CKD - chronic kidney disease</kwd>
<kwd>immunosurveillance</kwd>
<kwd>immune system</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cell Growth and Division</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Chronic kidney disease (CKD) affects a rapidly growing population worldwide. Patients with CKD are at a strongly increased risk for overall morbidity and mortality, and it is projected that by the year 2040, CKD will be the fifth leading cause of years of life lost in the world (<xref ref-type="bibr" rid="B10">Foreman et al., 2018</xref>). Advanced age is the strongest single risk factor for CKD and due to several overlapping features with physiological kidney aging CKD is often regarded as an accelerated aging process (<xref ref-type="bibr" rid="B35">Rex et al., 2023</xref>). One of the typical biological changes, which can be observed in both CKD and the old kidney, is an accumulation of cellular senescence (<xref ref-type="bibr" rid="B31">Mylonas and Ferenbach, 2024</xref>).</p>
<p>Cellular senescence is an irreversible cell cycle arrest, which is associated with changes in chromatin organization, gene transcription, metabolism and protein secretion. While cellular senescence is a crucial physiological process during healthy development, it can be harmful during later life if senescent cells accumulate in the body (<xref ref-type="bibr" rid="B12">Gorgoulis et al., 2019</xref>). Generally, cellular senescence occurs as a response to cellular stress, such as telomere shortening, DNA damage, oncogene activation, hypoxia, toxin exposure, energy or nutrient deprivation during aging and disease states (<xref ref-type="bibr" rid="B30">Mu&#xf1;oz-Esp&#xed;n and Serrano, 2014</xref>). Senescent cells upregulate different cell cycle inhibitors, mainly p16INKA and/or p21cip1, and activate pro-survival pathways to resist apoptosis. In most cell types, the senescent state is associated with an increased activity of the lysosomal hydrolase senescence-associated &#x3b2;-galactosidase (SA-&#x3b2;-Gal) and with a distinctive secretory phenotype consisting of various pro-inflammatory molecules and growth factors, known as senescence-associated secretory phenotype (SASP) (<xref ref-type="bibr" rid="B14">Huang et al., 2022</xref>; <xref ref-type="bibr" rid="B35">Rex et al., 2023</xref>). SASP molecules are thought to be crucial for the pathophysiological effects of senescent cells as they elicit inflammatory processes in the surrounding tissue, which, in the absence of an adequate immune response, may progress to chronic inflammation, fibrosis and tissue dysfunction.</p>
<p>The detrimental role of cellular senescence in the kidney has been highlighted by experimental work, in which elimination of senescent cells improved kidney regeneration and antagonized the progression of CKD and age-related changes (<xref ref-type="bibr" rid="B31">Mylonas and Ferenbach, 2024</xref>). Several groups, including ours, have found this causative interrelationship in mouse models of acute kidney injury (AKI), CKD and kidney transplantation (<xref ref-type="bibr" rid="B15">Johmura et al., 2021</xref>; <xref ref-type="bibr" rid="B32">Mylonas et al., 2021</xref>; <xref ref-type="bibr" rid="B19">Li et al., 2023</xref>; <xref ref-type="bibr" rid="B20">Liao et al., 2022</xref>). While most of these studies achieved a clearance of senescent cells via the administration of cell death-inducing chemical agents, often referred to as &#x201c;senolytics,&#x201d; another strategy could involve immunotherapies, which foster the natural immune clearance of senescent cells (<xref ref-type="bibr" rid="B31">Mylonas and Ferenbach, 2024</xref>).</p>
<p>Physiologically, the immune system plays a crucial role in senescence surveillance by maintaining an ongoing clearance of senescent cells, with macrophages, T-cells and natural killer (NK) cells being the primary actors in this process (<xref ref-type="bibr" rid="B16">Kale et al., 2020</xref>). Through several still underexplored receptor-ligand interactions, immune cells are able to detect and eliminate senescent cells (<xref ref-type="bibr" rid="B36">Salminen, 2021</xref>). SASP factors are believed to shape the senescent microenvironment and set the ground for immune cell recruitment, but research on the involved signaling pathways has been challenging as the SASP composition is highly variable according to cell-type, senescence stage and senescent phenotype (<xref ref-type="bibr" rid="B12">Gorgoulis et al., 2019</xref>; <xref ref-type="bibr" rid="B33">Oguma et al., 2023</xref>). Importantly, for various reasons, immune cells may encounter challenges in an effective elimination mechanism. While immunological senescence surveillance is highly efficient during development, it is compromised in advanced age or in situations where the immune system is suppressed (e.g., by immunosuppressive drugs after allogenic organ transplantation). In these scenarios, senescent cells can accumulate in tissues, such as the kidney, and contribute to structural and functional decline (<xref ref-type="bibr" rid="B28">Moiseeva et al., 2023</xref>). Restoring the immune response towards the elimination of senescent cells may hold important therapeutic potential for improved outcomes in AKI, CKD and kidney transplantation (<xref ref-type="bibr" rid="B16">Kale et al., 2020</xref>; <xref ref-type="bibr" rid="B24">Matsunaga et al., 2021</xref>). As NK cells have been primarily involved in the elimination of senescent cells, adoptive NK cell therapy has been suggested as a strategy to fight age-related disease and promote longevity (<xref ref-type="bibr" rid="B7">Deng and Terunuma, 2024</xref>).</p>
<p>The interaction between immune cells and senescent cells of the kidney has not been studied in detail so far. In particular, there is a complete research gap about the relationship between NK cells and senescent tubular epithelial cells, the most abundant cell type of the kidney. A better understanding of this interaction constitutes a promising axis with potential opportunities for therapeutic strategies. Our primary goal in this study was therefore to characterize the interactions between NK cells and kidney tubular cells. To this end, we established a primary tubular epithelial cell (PTEC) <italic>in vitro</italic> model based on NK cell activity to identify decisive receptors and ligands involved in the cell-cell interaction with senescent target cells. Subsequently, we addressed the impact of exogenous substances and medications, which might modulate the mechanisms underlying the clearance of senescent tubular cells.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec sec-type="ethics-statement" id="s2-1">
<title>Ethics statement</title>
<p>All mouse experimental protocols were approved by the local animal welfare authorities (Niedersaechsisches Landesamt f&#xfc;r Verbraucherschutz und Lebensmittelsicherheit, LAVES, Oldenburg, Germany) and performed according to local animal welfare law (animal welfare protection act) under license number: 2022/306 (reviewed by LAVES).</p>
</sec>
<sec id="s2-2">
<title>Extraction of murine primary cells</title>
<p>All mice were bred at Hannover Medical School (Central Animal Laboratory and Institute for Laboratory Animal Science) and housed under standard pathogen-free conditions in accordance with local animal welfare regulations. Primary tubular epithelial cells (PTEC) were isolated as described previously (<xref ref-type="bibr" rid="B20">Liao et al., 2022</xref>). PTEC were isolated from euthanized donor C57BL/6, B6N; 129-Ncr1tm1Oman/J, (B6 Ncr1GFPxB6, tm/wt), B6.129(ICR)Tg(CAGECFP)CK6Nagy/J or B6N; 129-NCr1tm1Oman/J (B6 GFP tm/tm) mice. Perforin-deficient NK cells were isolated from perforin-deficient C57BL/6-Prf1tm1Sdz/J mice (JAX stock &#x23;002407) as described previously (<xref ref-type="bibr" rid="B13">Halle et al., 2016</xref>; <xref ref-type="bibr" rid="B23">Lueder et al., 2018</xref>). Donor mice were euthanized by CO2 narcosis and cervical dislocation and kidneys were manually dissected and digested in 0.125% Collagenase Type I (Affymetrix/USB) solution (37&#xb0;C; 45 min). The sediment was centrifuged (5 min; 300 g) and sieved through 40 &#x3bc;m cell strainers. Cells were cultured in REGM2 medium (Promocell) in 6 cm dishes. Confluent PTEC were exposed to &#x3b3;-irradiation (&#x3b3;-ray, 10 Gray) on day 6 after extraction to induce synchronized senescence. Senescence load was checked by senescence associated-beta-galactosidase (SA-&#xdf;-Gal) activity and qPCR (Cdkn2a). Cells were transferred to six-well plates on day 7. On day 14 cells were treated according to the experimental protocol and then transferred to 96-well plates on day 15. NK cells were added on day 16 and the read-out was performed on day 20.</p>
<p>For NK cell isolation on day 16, the NK Cell Isolation Kit Mouse was used (Miltenyi Biotec, number 130-115-818). Spleens from C57BL/6N strains B6N; 129-Ncr1tm1Oman/J and B6.129(ICR)-Tg(CAG-ECFP)CK6Nagy/J or C57BL/6-Prf1tm1Sdz/J mice were sieved through 30 &#x3bc;m cell strainers and labelled with the biotin-labelled antibody mix (Miltenyi Biotec). After 5 min incubation on ice, the sedimented cells (10 min, 300 g) were resuspended with buffer and anti-Biotin Micro Beads and incubated (10 min; 2&#xb0;C&#x2013;8&#xb0;C). Cells were separated with LS-columns and resuspended with REGM2.</p>
</sec>
<sec id="s2-3">
<title>Cell culture experiment</title>
<p>IL-7, and IL-15 (Sigma; Preprotech) were added to the PTEC culture at a concentration of 10 &#x3bc;g/mL on day 16; Cyclosporin A at a concentration of 10 mM and NKG2D-R-Antibody (BioTechne; MAB1547) at a concentration of 2 &#x3bc;g/mL. Respective controls were run in parallel as well as non-senescent PTEC cultures (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Number of PTEC was counted by DAPI staining and the senescence load was quantified by SA-&#xdf;-Gal staining. Per condition, three wells with 8 HPFs (magnification &#xd7;400) each were used for quantification. Images were analyzed with ImageJ (<xref ref-type="bibr" rid="B38">Schneider et al., 2012</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Senescent renal tubular epithelial cells increase NK cell activity <italic>in vitro</italic>. <bold>(A)</bold> Schematic of the experimental set-up of the co-culture between &#x3b3;-irradiated senescent and non-senescent cells (Created by Biorender). <bold>(B)</bold> Quantification of SA-&#xdf;-Gal positive area (%) between senescent (d16 irradiated, IR) and non-senescent (d6 non-irradiated, NIR) cells. <bold>(C)</bold> Relative gene expression of Cdkn2a (p16INK4A) in primary tubular epithelial cells (PTEC). <bold>(D)</bold> Number of NK cell clusters per well. <bold>(E, F)</bold> Representative images of NK cell clusters (marked by arrows) in non-senescent (d6 NIR) and senescent (d16 IR) co-cultures. Inserts show magnifications with encircled clusters. <bold>(G)</bold> Senescent co-culture NK cells (GFP&#x2b;) at 0 and 8 h, NK cell clusters are encircled (<xref ref-type="sec" rid="s12">Supplementary Video S1</xref>). <bold>(H)</bold> Non-senescent co-culture NK cells (GFP&#x2b;) at 0 and 8 h. Statistical significance was determined using one-way ANOVA or a non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01; &#x2a;&#x2a;&#x2a;p &#x3c; 0.001. Pooled data from three biological replicates in three repetitions are shown per experiment (Figure <bold>(B)</bold> &#x2b; <bold>(D)</bold>). Pooled data from four biological replicates are shown per experiment. Original magnification in <bold>(E&#x2013;H)</bold> &#xd7;400. Scale bars, 30 &#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-13-1597230-g001.tif">
<alt-text content-type="machine-generated">Experimental setup showing mice subjected to radiation and non-irradiation processes, followed by cell culture and analysis at various time points. Bar graphs (B, C, D) display quantitative results for SA-&#xDF;-Gal positive area, gene expression, and cluster numbers, highlighting significant differences. Microscopy images (E, F) show cellular clusters with arrows indicating specific features in irradiated and non-irradiated samples. Panels (G, H) display fluorescence images of NK cells at different time intervals, showing cell distribution and clustering.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-4">
<title>Microscopy</title>
<p>For live cell imaging, a Zeiss 980 microscope at the Research Core Unit for Laser Microscopy of the Hannover Medical School was used. After adding NK cells to the PTEC, the co-culture was filmed for 7 h (GFP/CFP picture/3 min). Fiji was used for data transformation (<xref ref-type="bibr" rid="B37">Schindelin et al., 2012</xref>).</p>
</sec>
<sec id="s2-5">
<title>Real-time RT-PCR</title>
<p>Non-irradiated and irradiated PTEC were used as seen above. NucleoSpin RNA Plus kits (Machery-Nagel) were used for isolation of RNA and a Lightcycler 480 System (Roche) was used for RNA expression quantification. Sybr green master mix was used together with primers (Eurofins genomic) for Cdkn2a (f: <italic>CGAACTCTTTCGGTCGTACCC</italic>; r: <italic>CGAATCTGCACCGTAGTTGAGC</italic>), H60b (f: <italic>AGCCTGAGAGAGCTTTCAGAA</italic>; r: <italic>GGGTGTCAGAATTATGTTGGGAG</italic>), Mult-1 (f: CAATGTCTCTGTCCTCGGAA; r: CTGAACACGTCTCAGGCACT), Mill-2 (f: TTTGGGCTGTGAGCTTCTGAG; r: AGTCCTGGTCCTGTCCTTTGT). For quantification, LightCycler 96 SW 1.1was used and the relative mRNA levels were calculated according to the 2<sup>&#x2212;&#x394;&#x394;Ct</sup> method; all samples were normalized to HPRT/actin gene expression.</p>
</sec>
<sec id="s2-6">
<title>Flow cytometry</title>
<p>PTEC in 6 cm dishes were harvested by gentle scraping and resuspended in REGM2 medium (Promocell). Viablity was checked by microscopy and counting of viable cells (VI-Cell, Beckman). The harvested PTEC were stained with the Mult-1 antibody (rat anti-MULT1, clone 1D6, Millipore MABS1906) or H60 antibody (goat anti-H60, Thermo Fischer, PA5-47081) and then washed and stained with the corresponding secondary antibodies, anti-rat APC (Invitrogen, A10540) or anti-goat A647 (Jackson, 205-165-108). After washing with PBS/FCS, stained cells were measured using a BD FACSymphony A1 Cell Analyzer.</p>
</sec>
<sec id="s2-7">
<title>Statistical analysis</title>
<p>Statistical significance was determined using the nonparametric Mann-Whitney test and One-way ANOVA with GraphPad Prism Software. The significance level was set to p &#x3c; 0.05. No power calculation and no randomization was performed. The interpretation of results in this study primarily rests on the reproducibility of the results and the observed effect size, as shown in each figure by visualization of each individual sample (by a combination of dot plots and error bars). All methods are reported in accordance with ARRIVE guidelines.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Senescent renal tubular epithelial cells increase NK cell activity <italic>in vitro</italic>
</title>
<p>To study the interactions between NK cells and senescent tubular cells we established a murine <italic>in vitro</italic> model (<xref ref-type="fig" rid="F1">Figure 1A</xref>). To this end, we used our standardized protocol of cellular senescence induction in PTEC, in which short-term cultured PTEC serve as non-senescent control (<xref ref-type="bibr" rid="B20">Liao et al., 2022</xref>; <xref ref-type="bibr" rid="B21">Liao et al., 2021</xref>; <xref ref-type="bibr" rid="B4">Berkenkamp et al., 2014</xref>). PTEC were isolated from mouse kidneys and senescence was induced by &#x3b3;-irradiation followed by prolonged cell culture duration (16 days in total), while non-senescent control PTEC were only cultured for 5 days (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Subsequently, spleen-derived murine NK cells were added, and the renal epithelial cells were co-cultured with the NK cells for 96 h. Analysis was performed by light-microscopy, fluorescence microscopy, histochemistry or quantitative PCR (qPCR).</p>
<p>In this culture system, we first confirmed the induction of cellular senescence by established senescence markers SA-&#xdf;-Gal (<xref ref-type="fig" rid="F1">Figure 1B</xref>) and Cdkn2a/p16INKA (<xref ref-type="fig" rid="F1">Figure 1C</xref>). After senescence induction by &#x3b3;-irradiation, we found that the cultured epithelial cells showed up to &#x223c;14% SA-&#xdf;-Gal stained surface area positivity. In contrast, control cultures without irradiation showed only &#x223c;6% SA-&#xdf;-Gal staining (&#x223c;60% reduction, p &#x3d; 0.0002, <xref ref-type="fig" rid="F1">Figure 1B</xref>). Accordingly, the senescence marker Cdkn2a was &#x223c;45 times higher expressed in the irradiated epithelial cells (p &#x3d; 0.0339, <xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<p>Next, we analyzed co-cultures of PTEC and purified mouse NK cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>). To quantify NK cell activity on the single cell level by microscopy, a cell-clustering analysis was performed. A cluster of NK cells was defined according to three criteria (&#x201c;NK cell triad&#x201d;): the cluster contains a minimum of six NK cells per cluster (1), which overlap each other, as a sign of attacking the senescent cell (2) and GFP positivity (3) as an indicator of NK cell survival.</p>
<p>On day 4 after NK cell co-culture, we observed numerous clusters of viable NK cells in culture wells with &#x3b3;-irradiated PTEC (<xref ref-type="fig" rid="F1">Figure 1D</xref>). All wells containing senescence-induced PTEC contained such clusters of NK cells (<xref ref-type="fig" rid="F1">Figures 1D, F</xref>). In contrast, NK cells rarely formed clusters in the PTEC cultures without &#x3b3;-irradiation (<xref ref-type="fig" rid="F1">Figures 1D, E</xref>). A systematic comparison between the senescent and non-senescent co-culture from multiple independent experiments revealed significantly more clusters in the senescent group, suggesting a stronger NK cell activity (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>).</p>
<p>To support our findings by visualization with another technique, we next used live cell imaging. We visualized co-cultures of non-/senescent cells and NK cells (GFP&#x2b;) for 8 hours. While there was a strong decrease in the number of NK cells in the non-senescent co-culture over time, we noticed sustained survival and a strong clustering of NK cells around senescent PTEC (<xref ref-type="fig" rid="F1">Figures 1G, H</xref> and <xref ref-type="sec" rid="s12">Supplementary Movie 1</xref>). This observation supports the assumption of a more aggressive attack and longer surviving NK cells in the presence of senescent target cells (<xref ref-type="fig" rid="F1">Figures 1G, H</xref>). Taken together, we generated a mouse renal tubular epithelial cell culture system that allowed observing senescence-correlated clustering of NK cells.</p>
</sec>
<sec id="s3-2">
<title>Clearance of senescent tubular cells by NK cells</title>
<p>Having observed a clustering of NK cells in cultures of senescent PTEC, we asked whether local NK cell activity might affect the number of viable PTEC in the culture. Using the same protocol of senescence induction and NK cell co-culture from <xref ref-type="fig" rid="F1">Figure 1</xref>, we compared the number of PTEC (DAPI staining) and senescence load (SA-&#xdf;-Gal staining and transcript levels of Cdkn2a) between senescent PTEC and co-culture with senescent PTEC and NK cells (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;C</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Clearance of senescent tubular cells by NK cells. <bold>(A)</bold> Number of PTEC (DAPI staining) cultured without NK cells (NK&#x2212;) and co-cultured with NK cells (NK&#x2b;) (normalized % to NK&#x2212;). <bold>(B)</bold> SA-&#xdf;-Gal positive area (normalized to NK&#x2212;). <bold>(C)</bold> Relative gene expression of Cdkn2a. <bold>(D, E)</bold> Representative pictures of SA-&#xdf;-Gal staining of PTEC without NK cells (NK&#x2212;) versus co-cultured with NK cells (NK&#x2b;) and <bold>(F, G)</bold> corresponding DAPI staining. Statistical significance was determined using a non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01; &#x2a;&#x2a;&#x2a;p &#x3c; 0.001. Pooled data from five biological replicates in three repetitions are shown per experiment (Figure <bold>(A)</bold> &#x2b; <bold>(B)</bold>). Pooled data from six biological replicates (Figure <bold>(C)</bold>). Original magnification in <bold>(D&#x2013;G)</bold> is &#xd7;400. Scale bars, 30 &#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-13-1597230-g002.tif">
<alt-text content-type="machine-generated">Graphs and images show the effects of NK treatment on PTEC. Graphs A and B depict that NK&#x2b; treatment reduces the number of PTEC and SA-&#x3B2;-Gal positive area with statistical significance (p&#x3C;0.01 and p&#x3C;0.001). Graph C displays similar Cdkn2a expression between NK- and NK&#x2b; groups (p&#x3d;0.053). Blue-stained images D and E show SA-&#x3B2;-Gal staining in NK- and NK&#x2b; groups, respectively. Fluorescent images F and G depict DAPI staining of nuclei in NK- and NK&#x2b; groups.</alt-text>
</graphic>
</fig>
<p>We counted the number of viable PTEC per well and compared wells treated or non-treated with NK cells (<xref ref-type="fig" rid="F2">Figure 2A</xref>). We found that addition of NK cells reduced the number of PTEC around 20% (p &#x3d; 0.0036; <xref ref-type="fig" rid="F2">Figures 2A, F, G</xref>). Next, we asked whether the senescent load can be reduced by NK cell treatment. As measured by SA-&#xdf;-Gal staining, NK cell treatment led to the reduction of SA-&#xdf;-Gal positivity by around 14% (p &#x3d; 0.0001; <xref ref-type="fig" rid="F2">Figures 2B, D, E</xref>). By qPCR, we saw a borderline significant reduction of Cdkn2a expression in PTEC after NK cell treatment (p &#x3d; 0.053; <xref ref-type="fig" rid="F2">Figure 2C</xref>). Taken together, the number of PTEC and the senescent load (SA-&#xdf;-Gal) were strongly reduced in the NK cell co-culture group, indicating a decrease of senescent cells through the NK cells. These findings indicate a specific identification and clearance of senescent PTEC through NK cells.</p>
</sec>
<sec id="s3-3">
<title>Perforin-dependent killing of senescent renal epithelial cells</title>
<p>NK cells can eliminate target cells by different mechanisms (<xref ref-type="bibr" rid="B6">Crinier et al., 2018</xref>). To elucidate the intercellular processes between NK cells and senescent PTEC, perforin-deficient NK cells (perf <sup>&#x2212;/&#x2212;</sup>) were used (<xref ref-type="bibr" rid="B13">Halle et al., 2016</xref>; <xref ref-type="bibr" rid="B23">Lueder et al., 2018</xref>). The same experimental set-up was used as in the experiment above, but now with co-cultures of senescent PTEC either with perforin-sufficient (perf <sup>&#x2b;/&#x2b;</sup>) or with (perf <sup>&#x2212;/&#x2212;</sup>) NK cells. Both groups were compared to senescent PTEC without NK cells.</p>
<p>The perf<sup>&#x2b;/&#x2b;</sup> NK cell group showed clearance of senescent PTEC consistent with our data from <xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2</xref>. Specifically, the perf<sup>&#x2b;/&#x2b;</sup> NK cell group showed a reduction of around 25% in PTEC number (<xref ref-type="fig" rid="F3">Figures 3A, E, F</xref> compared to the perf<sup>&#x2b;/&#x2b;</sup> NK cell group used for normalization). The perforin-expressing NK cells also triggered a 35 %-reduction in the SA-&#xdf;-Gal area (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;F</xref>). In contrast, the perforin-deficient NK cells (perf<sup>&#x2212;/&#x2212;</sup>) did not reduce PTEC numbers or the senescence load (<xref ref-type="fig" rid="F3">Figures 3A, B</xref>). Thus, the NK cell-mediated attack on senescent renal tubular epithelial cells depends on perforin-mediated killing of senescent target cells.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Perforin-dependent killing of senescent renal epithelial cells. <bold>(A)</bold> Quantification of DAPI-stained cells (number of PTEC) after co-culture with perforin-competent NK cells (perf<sup>&#x2b;/&#x2b;</sup>) and perforin-deficient NK cells (perf<sup>&#x2212;/&#x2212;</sup>) (normalized to perf<sup>&#x2212;/&#x2212;</sup> NK cell group). <bold>(B)</bold> Quantification of SA-&#xdf;-Gal positive area after co-culture of PTEC with perf<sup>&#x2b;/&#x2b;</sup> and perf<sup>&#x2212;/&#x2212;</sup> NK cells (normalized to perf<sup>&#x2212;/&#x2212;</sup> NK cell group). <bold>(C, D)</bold> Representative pictures of SA-&#xdf;-Gal staining of PTEC after co-culture with perf<sup>&#x2b;/&#x2b;</sup> and perf<sup>&#x2212;/&#x2212;</sup> NK cells and <bold>(E, F)</bold> corresponding DAPI staining for cell quantification. Statistical significance was determined using a non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01. Pooled data from five biological replicates in three repetitions are shown per experiment. Original magnification in <bold>(C&#x2013;F)</bold> is &#xd7;400. Scale bars, 30 &#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-13-1597230-g003.tif">
<alt-text content-type="machine-generated">Graphs A and B show a significant increase in both the number of PTEC and SA-&#x3B2;-Gal positive area in NK perf -/- mice compared to NK perf &#x2b;/&#x2b; mice. Micrographs C and D display SA-&#x3B2;-Gal staining in kidney sections, with more intense staining in NK perf -/- mice. Images E and F show DAPI staining of nuclei, with similar cell distribution in both genotypes.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>NKG2D plays a crucial role in the clearance of senescent renal epithelial cells</title>
<p>To investigate the activating receptor on NK cells for senescent PTEC clearance, a NKG2D antibody was employed to block receptor-ligand interaction between senescent PTEC and NK cells. NKG2D has been shown to modulate immune cell activation by senescent cells (<xref ref-type="bibr" rid="B47">Yang et al., 2023</xref>; <xref ref-type="bibr" rid="B8">Deng et al., 2024</xref>). In our study, the NKG2D-blocking antibody showed an effect, resulting in a lower activity of NK cells. In comparison to the non-treated group, the antibody-treated group showed a higher number of PTEC (25%; p &#x3d; 0.002) and senescence load (40%; p &#x3d; 0.0001) (<xref ref-type="fig" rid="F4">Figures 4A, B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>NKG2D plays a crucial role in clearance of senescent renal epithelial cells. <bold>(A)</bold> Quantification of DAPI-stained cells (number of PTEC) comparing senescent PTEC without NK cells (NK&#x2212;), co-cultured with NK cells (NK&#x2b;) and co-cultured with NK cells and NKG2D-antibody (AK) (normalized to NK&#x2212; group). <bold>(B)</bold> Quantification of SA-&#xdf;-Gal positive area for the same groups as in <bold>(A)</bold>. <bold>(C)</bold> Heatmap of NKG2D-receptor ligands; data extracted from previously published bulk RNA-seq data of non-senescent (ns) and senescent (sen) PTEC (relative expression) (<xref ref-type="bibr" rid="B40">Sinning et al., 2023</xref>). <bold>(D&#x2013;F)</bold> Quantification of transcripts of NKG2D-receptor ligands H60b, Mill-2 and Mult-1 in non-senescent (d6 NIR) and senescent PTEC (d16 IR). Significance was tested by one-way ANOVA or non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01. Pooled data from four biological replicates in three repetitions are shown per experiment (Figure <bold>(A)</bold> &#x2b; <bold>(B)</bold>). Pooled data from five biological replicates (Figure <bold>(D)</bold> &#x2b; <bold>(F)</bold>). Pooled data from four biological replicates (Figure <bold>(E)</bold>).</p>
</caption>
<graphic xlink:href="fcell-13-1597230-g004.tif">
<alt-text content-type="machine-generated">Bar graphs (A, B) display normalized PTEC counts and SA-&#x3B2;-Gal-positive areas across four groups, with significant differences marked. A heatmap (C) shows expression levels of genes Mill-1, Mill-2, Ulbp-1, H60b, and H60c, with color intensity indicating expression. Bar graphs (D, E, F) illustrate relative gene expression of H60b, Mult-1, and Mill-2 at two time points, with significance noted.</alt-text>
</graphic>
</fig>
<p>Next, we asked which signals might be responsible for the senescence-triggered NK cell activity. We analyzed changes in the transcriptome of senescent PTEC using a previously described data set (<xref ref-type="bibr" rid="B40">Sinning et al., 2023</xref>). We found that mRNA levels of several NKG2D-receptor ligands were upregulated in senescent PTEC, including H60b, Mult-1 (Ulbp-1) and Mill-2 (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Expression levels in senescent PTEC were independently tested by qPCR confirming significant upregulation of mRNA for H60b, as well as Mult-1 (<xref ref-type="fig" rid="F4">Figures 4D&#x2013;F</xref>). Ligand expression in PTEC was also found on the protein level using flow cytometry with Mult-1 and H60 antibodies. However, protein upregulation in senescent PTEC was minimal when compared to the non-senescent cells, and the difference did not reach statistical significance (data not shown).</p>
</sec>
<sec id="s3-5">
<title>Pharmacological modulation of NK cell-mediated clearance of senescent tubular epithelial cells</title>
<p>Pharmacological immunosuppression and immunostimulatory cytokines can dramatically alter host target cells and immune cell functions. Therefore, we next wanted to test the influence of the immunosuppressive drug cyclosporine A (CsA) on NK cell-mediated clearance of renal tubular cells. In co-cultures with additional CsA, clearance of senescent PTEC by NK cells was strongly reduced. Compared to the non-treated co-culture, the number of PTEC remained significantly higher (by around 10%). Also, the SA-&#xdf;-Gal positive area after addition of CsA was larger by around 20% (<xref ref-type="fig" rid="F5">Figures 5A, B</xref>). These data support the idea that CsA can downregulate the NK cell-mediated clearance of senescent renal epithelial cells.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Pharmacological modulation of NK cell-mediated clearance of senescent tubular epithelial cells. <bold>(A)</bold> Quantification of senescent PTEC (DAPI staining) cultured without NK cells (NK&#x2212;), with NK cells (NK&#x2b;) and with NK cells in the presence of Cyclosporine A (CsA) (normalized to NK&#x2212;). <bold>(B)</bold> SA-&#xdf;-Gal positive area in PTEC cultures of the same groups as in <bold>(A)</bold>. <bold>(C)</bold> Quantification of senescent PTEC (DAPI staining) cultured without NK cells (NK&#x2212;), with NK cells (NK&#x2b;) and with NK cells in the presence of 10 &#x3bc;g/mL IL-7 (normalized to NK&#x2212;). <bold>(D)</bold> Quantification of SA-&#xdf;-Gal positive area in PTEC cultures of the same groups as in <bold>(C)</bold>. <bold>(E)</bold> Corresponding overview of SA-&#xdf;-Gal staining for experimental conditions of <bold>(C)</bold>. Significance was tested by one-way ANOVA or non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01; &#x2a;&#x2a;&#x2a;p &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;p &#x3c; 0.0001. Pooled data from three biological replicates in three repetitions are shown per experiment.</p>
</caption>
<graphic xlink:href="fcell-13-1597230-g005.tif">
<alt-text content-type="machine-generated">Graphs A to D display normalized data for the number of PTEC and beta-galactosidase positive areas, with significant differences indicated by asterisks. Graph A shows the number of PTEC, while B shows beta-gal positivity, comparing NK-negative, NK-positive, and NK with CsA groups. Graphs C and D focus similarly on NK-negative, NK-positive, and IL-7 NK-positive groups. E depicts a well plate with differentially stained wells corresponding to NK-negative, NK-positive, and IL-7 NK-positive conditions.</alt-text>
</graphic>
</fig>
<p>Conversely, adding interleukin 7 (IL-7) exhibited a stimulatory effect on NK cell-mediated clearance of senescent tubular cells. While there was a reduction in PTEC number of &#x223c;20% in the NK cell group, the addition of IL-7 was associated with a &#x223c;50% reduction. In parallel, the SA-&#xdf;-Gal stained area was significantly smaller when IL-7 was added to the co-culture (<xref ref-type="fig" rid="F5">Figures 5C&#x2013;E</xref>). The strong enhancement of NK cells by IL-7 correlated with low expression of IL-7 gene in senescent PTEC (<xref ref-type="sec" rid="s12">Supplementary Figure S1A</xref>). In contrast to IL-7, interleukin 15 (IL-15) showed only a trend in enhancing NK cell killing activity, while having no effect on the stained SA-&#xdf;-Gal area (<xref ref-type="sec" rid="s12">Supplementary Figures S1B&#x2013;D</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Harnessing NK cells for efficient clearance of senescent cells might provide a perspective to improve the outcome of kidney diseases and prolong kidney transplant survival (<xref ref-type="bibr" rid="B16">Kale et al., 2020</xref>). Our model is the first, to address direct interactions between NK cells and senescent kidney cells. We introduce a simple and robust protocol, which enables the visualization of NK cell-mediated effects on senescent renal tubular cells, as well as the quantification of NK cell activity. The model may serve as a platform for the development of novel therapies employing NK cell-based strategies for the clearance of senescent cells.</p>
<p>In our <italic>in vitro</italic> model, NK cells efficiently eliminated senescent renal epithelial cells and did not attack non-senescent cells. This observation is compatible with the notion that NK cells protect the kidney against an accumulation of cellular senescence during aging and in stress conditions. We focused purposefully on tubular cells, acknowledging that NK cell-mediated effects towards non-tubular kidney cell types (e.g., endothelial cells, interstitial fibroblasts) could be different. For example, ligands found on the surface of senescent dermal fibroblasts can inhibit NK cells via the NKG2A receptor and prevent clearance activity (<xref ref-type="bibr" rid="B34">Pereira et al., 2019</xref>; <xref ref-type="bibr" rid="B46">Wlaschek et al., 2021</xref>). While the kidney is among the most complex organs in terms of cell-type heterogeneity, tubular cells represent by far the majority of all kidney cells (<xref ref-type="bibr" rid="B39">Schumacher et al., 2021</xref>). Typical markers of senescence have been demonstrated consistently in aged and in stressed tubular cells across different rodent models and in human biopsies (<xref ref-type="bibr" rid="B31">Mylonas and Ferenbach, 2024</xref>). Thus, our primary tubular cell model provides a useful research tool for studying key mechanisms of anti-senescent effects in the kidney.</p>
<p>CKD is typically associated with a progressive loss of renal function, which may lead to terminal kidney failure and the need for dialysis or kidney transplantation. Kidney transplantation is the gold standard treatment option as it provides superior survival and better quality of life compared to dialysis (<xref ref-type="bibr" rid="B17">Kanbay et al., 2024</xref>). Although outcomes in kidney transplantation have improved over the last decades, the ongoing lack of organ availability, early graft loss due to graft rejection and side effects of immunosuppressive drugs continue to be major challenges. Undoubtedly, improved strategies to ameliorate kidney allograft health and to avoid functional deterioration have to be established. The therapeutic potential of targeting senescent tubular cells was underscored by data from zero-hour biopsies of human kidney allografts, in which the load of senescent cells correlated significantly with subsequent transplant outcomes during short- and long-term follow-up (<xref ref-type="bibr" rid="B18">Koppelstaetter et al., 2008</xref>; <xref ref-type="bibr" rid="B25">McGlynn et al., 2009</xref>; <xref ref-type="bibr" rid="B41">Sofue et al., 2018</xref>). Similarly, failing allografts contained strongly increased numbers of senescent cells (<xref ref-type="bibr" rid="B26">Melk et al., 2009</xref>; <xref ref-type="bibr" rid="B3">Arvizu-Hern&#xe1;ndez et al., 2010</xref>). In experimental transplantation models, cellular senescence correlated with kidney failure, whereas antagonizing cellular senescence improved the transplant outcome (<xref ref-type="bibr" rid="B27">Melk et al., 2005</xref>; <xref ref-type="bibr" rid="B5">Braun et al., 2012</xref>; <xref ref-type="bibr" rid="B20">Liao et al., 2022</xref>). Our co-culture model demonstrated that the calcineurin inhibitor CsA suppressed the capacity of NK cells to eliminate senescent tubular cells. This finding correlates with previous data showing reduced NK cell activity upon CsA exposure (<xref ref-type="bibr" rid="B29">Morteau et al., 2010</xref>; <xref ref-type="bibr" rid="B44">Wang et al., 2007</xref>). Correspondingly, the number of peripheral NK cells was significantly suppressed in transplant recipients treated with CsA (<xref ref-type="bibr" rid="B43">Vondran et al., 2012</xref>). Importantly, patients treated with belatacept, an alternative immunosuppressant, which blocks the CD80/86-CD28 co-stimulatory pathway of T-cells, maintained NK cell levels close to healthy controls (<xref ref-type="bibr" rid="B43">Vondran et al., 2012</xref>). Allografts of patients treated with belatacept accumulated significantly fewer senescent tubular cells over time when compared to CsA treated patients (<xref ref-type="bibr" rid="B11">Furuzawa-Carballeda et al., 2012</xref>). Together, these findings are compatible with the notion that CsA exposure leads to disturbed NK cell function and subsequent accumulation of cellular senescence, whereas treatment with belatacept allows healthier NK cell function and better anti-senescence surveillance. Although speculative, it seems plausible that this mechanism is a direct contributor to the demonstrated benefits and better long-term graft survival in belatacept treated transplant recipients (<xref ref-type="bibr" rid="B9">Divard et al., 2024</xref>; <xref ref-type="bibr" rid="B42">Vincenti et al., 2016</xref>).</p>
<p>Therapies to enable and improve immune cell function often involve immune stimulatory factors. We found that IL-7 significantly enhanced the senolytic efficiency of NK cells in our culture system, while IL-15 had only minor effects. However, broad enhancement of immune cell activity by cytokines might have unspecific and difficult-to-control effects. In the renal field, this could be particularly challenging, because the immune response is often overactive, e.g., autoimmune disease or allogeneic kidney transplantation. As an alternative, it has been suggested to implement specific antigen-directed therapies, which allow clearance of senescent cells with high selectivity. Promising results in eliminating senescent cells have been obtained with chimeric antigen receptor (CAR) T-cells (<xref ref-type="bibr" rid="B8">Deng et al., 2024</xref>; <xref ref-type="bibr" rid="B47">Yang et al., 2023</xref>; <xref ref-type="bibr" rid="B1">Amor et al., 2024</xref>; <xref ref-type="bibr" rid="B2">Amor et al., 2020</xref>). In the first study using this strategy, CAR T-cells were developed to target the protein urokinase-type plasminogen activator receptor (uPAR) (<xref ref-type="bibr" rid="B2">Amor et al., 2020</xref>). Although this approach achieved an efficient clearance of senescent cells, it is questionable whether it is applicable to the diseased kidney, where uPAR is broadly expressed in different cell types during cell stress and does not seem to correlate well with cellular senescence (<xref ref-type="bibr" rid="B48">Zhang and Eddy, 2008</xref>). An alternative strategy employs NKG2D-CAR T-cells, which exploit the increased expression of NKG2D ligands on the surface of senescent cells (<xref ref-type="bibr" rid="B8">Deng et al., 2024</xref>). NKG2D ligands can mediate activating signals to attacking NK cells, as has been described in the context of immune cell-mediated attack on virus-infected cells (<xref ref-type="bibr" rid="B45">Wensveen et al., 2018</xref>). Therefore, we were interested in the impact of NKG2D signals on NK cell-mediated attack on senescent renal tubular epithelial cells. In fact, we found NKG2D receptor ligands, particularly H60b and Mult-1, to be significantly upregulated on the mRNA level in our data for senescent cells and blocking of the NKG2D receptor blunted the activity of NK cells towards senescent cells. Fittingly, it was shown that significant reductions of senescent cells achieved by NKG2D-CAR T cells were paralleled by a decrease in Mult-1 and H60b expression in various tissues including the kidney (<xref ref-type="bibr" rid="B47">Yang et al., 2023</xref>). With a focus on Mult-1 and H60b as potential ligands, we found a senescence-associated upregulation of mRNA levels in PTEC, but as this relative upregulation in senescent compared non non-senescent cells was not found on the protein level, additional ligands are likely to be involved.</p>
<p>The present study has some limitations. The first limitation is the fact that we restricted our research to the interaction of only two specific cell types (i.e., NK cells and tubular cells), which does not allow to capture the inherent complexity of the multi-cell type situation in the kidney. Mechanisms of NK cell interaction with other kidney cell types, such as endothelial cells and fibroblasts have not been addressed in our study. Together with other modifying factors of the internal milieu (e.g., cytokines) it is likely that the presence of other neighbouring cell types could have impacted our results. This should be studied in future studies. Another limitation of our model is that we here have focused on mouse cells. Given the discrepancies in ligands between human and murine cells (<xref ref-type="bibr" rid="B22">Liu et al., 2019</xref>), future experiments will have to include human tubular epithelial cells and NK cells. Additionally, future studies will have to validate the findings in animal experiments <italic>in vivo</italic> and should attempt to include clinical sample validation.</p>
<p>In summary, we introduce a novel easy-to-use cell culture model, which may serve as a platform to study NK cell-based strategies for the clearance of senescent kidney cells. Our data show the pivotal involvement of NKG2D receptor signaling with a potential involvement of ligands like H60b and Mult-1 in the NK cell-mediated elimination of senescent renal tubular cells. Understanding the mechanisms of immunosurveillance by which senescent cells are controlled and eliminated by the immune system presents a promising way for the development of therapeutic interventions to mitigate age-related or senescence-associated kidney disorders.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The animal study was approved by Niedersaechsisches Landesamt f&#xfc;r Verbraucherschutz und Lebensmittelsicherheit, LAVES, Oldenburg, Germany. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>NF: Formal Analysis, Investigation, Methodology, Software, Visualization, Writing &#x2013; review and editing. JS: Data curation, Investigation, Software, Writing &#x2013; review and editing. PS: Methodology, Formal Analysis, Writing &#x2013; review and editing. IS-Z: Methodology, Supervision, Writing &#x2013; review and editing. VW: Data curation, Formal Analysis, Investigation, Methodology, Writing &#x2013; review and editing. KS-O: Funding acquisition, Resources, Supervision, Validation, Writing &#x2013; review and editing. KB: Formal Analysis, Investigation, Software, Writing &#x2013; review and editing. SH: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review and editing. RS: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported in parts by Niedersaechsische Ministerium f&#xfc;r Wissenschaft und Kultur (MWK), project title: &#x201c;NKG2D-Signaling Plays a Crucial Role in Natural Killer Cell-Mediated Clearance of Senescent Renal Tubular Epithelial Cells;&#x201d; and in parts by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) &#x2013; Projektnummer 158989968 - SFB 900 (SH), SCHM2146/10-1 (RS), SCHM 2146/11-1 (RS).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2025.1597230/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2025.1597230/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<caption>
<p>
<bold>SUPPLEMENTARY FIGURE S1</bold>
</p> <p>
<bold>(A, B)</bold> Quantification of transcripts of interleukin 7 (IL-7) and interleukin 15 (IL-15) comparing non-senescent (d6 NIR) and senescent PTEC (d16 IR). <bold>(C)</bold> Quantification of PTEC (DAPI staining) comparing senescent PTEC after culture with NK cells (NK&#x2b;) and with additional IL-15 (normalized to NK&#x2212;). <bold>(D)</bold> SA-&#xdf;-Gal positive area for PTEC cultures corresponding to experimental conditions of <bold>(C)</bold> (normalized to NK&#x2212;). Significance was tested by one-way ANOVA or non-parametric Mann-Whitney test; &#x2a;p &#x3c; 0.05; &#x2a;&#x2a;p &#x3c; 0.01; ns, non-significant. Pooled data from at three independent experiments are shown, with a minimum of five biological replicates.</p>
</caption>
</supplementary-material>
<supplementary-material>
<caption>
<p>
<bold>SUPPLEMENTARY VIDEO S1</bold>
</p>
<p>
<bold>(A)</bold> Fluorescence microscopy video 1: NK cells (GFP&#x2b;) and non-senescent PTEC (RFP&#x2b;) for 8 h. <bold>(B)</bold> Fluorescence microscopy video 2: NK cells (GFP&#x2b;) and senescent PTEC (RFP&#x2b;) for 8 h.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Video2.avi" id="SM1" mimetype="application/avi" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.tif" id="SM2" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video1.avi" id="SM3" mimetype="application/avi" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amor</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Maestre</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Nadella</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction</article-title>. <source>Nat. Aging</source> <volume>4</volume>, <fpage>336</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1038/s43587-023-00560-5</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amor</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Feucht</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leibold</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alonso-Curbelo</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Senolytic CAR T cells reverse senescence-associated pathologies</article-title>. <source>Nature</source> <volume>583</volume>, <fpage>127</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2403-9</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arvizu-Hern&#xe1;ndez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morales-Buenrostro</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Vilatoba-Chapa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mancilla-Urrea</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Uribe-Uribe</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Avila-Casado</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: implications for function outcome</article-title>. <source>Transpl. Proc.</source> <volume>42</volume>, <fpage>2486</fpage>&#x2013;<lpage>2492</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2010.04.068</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkenkamp</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Susnik</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baisantry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuznetsova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jacobi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>S&#xf6;rensen-Zender</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>
<italic>In vivo</italic> and <italic>in vitro</italic> analysis of age-associated changes and somatic cellular senescence in renal epithelial cells</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e88071</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0088071</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B. M. W.</given-names>
</name>
<name>
<surname>Raiss</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baisantry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mircea-Constantin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Cellular senescence limits regenerative capacity and allograft survival</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>23</volume>, <fpage>1467</fpage>&#x2013;<lpage>1473</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2011100967</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crinier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Milpied</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Escali&#xe8;re</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Piperoglou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galluso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Balsamo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice</article-title>. <source>Immunity</source> <volume>49</volume>, <fpage>971</fpage>&#x2013;<lpage>986.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.09.009</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Terunuma</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics</article-title>. <source>Immun. Ageing</source> <volume>21</volume>, <fpage>43</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1186/s12979-024-00451-2</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schaaf</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scifo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morsy</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Targeting senescent cells with NKG2D-CAR T cells</article-title>. <source>Cell. Death Discov.</source> <volume>10</volume>, <fpage>217</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41420-024-01976-7</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Divard</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aubert</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Debiais-Deschamp</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goutaudier</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sablik</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Long-term outcomes after conversion to a belatacept-based immunosuppression in kidney transplant recipients</article-title>. <source>Clin. J. Am. Soc. Nephrol.</source> <volume>19</volume>, <fpage>628</fpage>&#x2013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.2215/CJN.0000000000000411</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foreman</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Marquez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dolgert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fukutaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fullman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>McGaughey</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories</article-title>. <source>Lancet</source> <volume>392</volume>, <fpage>2052</fpage>&#x2013;<lpage>2090</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31694-5</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuzawa-Carballeda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alber&#xfa;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Palafox</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Uribe-Uribe</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morales-Buenrostro</surname>
<given-names>L. E.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4&#x3b1; senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A</article-title>. <source>Clin. Exp. Immunol.</source> <volume>167</volume>, <fpage>330</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2011.04504.x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorgoulis</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Alimonti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Bischof</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cellular senescence: defining a path forward</article-title>. <source>Cell</source> <volume>179</volume>, <fpage>813</fpage>&#x2013;<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.10.005</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Keyser</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Busche</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marquardt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>
<italic>In vivo</italic> killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity</article-title>. <source>Immunity</source> <volume>44</volume>, <fpage>233</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.010</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hickson</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Eirin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kirkland</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Lerman</surname>
<given-names>L. O.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cellular senescence: the good, the bad and the unknown</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>18</volume>, <fpage>611</fpage>&#x2013;<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-022-00601-z</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johmura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Omori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Sugiura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders</article-title>. <source>Science</source> <volume>371</volume>, <fpage>265</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb5916</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kale</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stolzing</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Desprez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Campisi</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Role of immune cells in the removal of deleterious senescent cells</article-title>. <source>Immun. Ageing</source> <volume>17</volume>, <fpage>16</fpage>&#x2013;<lpage>19</lpage>. <comment>eCollection 2020</comment>. <pub-id pub-id-type="doi">10.1186/s12979-020-00187-9</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanbay</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Copur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guldan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>A. U.</given-names>
</name>
<name>
<surname>Ozbek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hasbal</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Imlifidase in kidney transplantation</article-title>. <source>Clin. Kidney J.</source> <volume>17</volume>, <fpage>sfae033</fpage>. <pub-id pub-id-type="doi">10.1093/ckj/sfae033</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koppelstaetter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schratzberger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Perco</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mark</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ollinger</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation</article-title>. <source>Aging Cell</source> <volume>7</volume>, <fpage>491</fpage>&#x2013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2008.00398.x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H. F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity</article-title>. <source>JCI Insight</source> <volume>8</volume>, <fpage>e166643</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.166643</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wulfmeyer</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Erlangga</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sinning</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>von M&#xe4;ssenhausen</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Induction of ferroptosis selectively eliminates senescent tubular cells</article-title>. <source>Am. J. Transpl.</source> <volume>22</volume>, <fpage>2158</fpage>&#x2013;<lpage>2168</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.17102</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wulfmeyer</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Swallow</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Falk</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Korstanje</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Induction of stress-induced renal cellular senescence <italic>in vitro:</italic> impact of mouse strain genetic diversity</article-title>. <source>Cells</source> <volume>10</volume>, <fpage>1437</fpage>. <pub-id pub-id-type="doi">10.3390/cells10061437</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Role of NKG2D and its ligands in cancer immunotherapy</article-title>. <source>Am. J. Cancer. Res.</source> <volume>9</volume>, <fpage>2064</fpage>&#x2013;<lpage>2078</lpage>.</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lueder</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Heller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ritter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Keyser</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells</article-title>. <source>PLoS Pathog.</source> <volume>14</volume>, <fpage>e1007252</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007252</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsunaga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iske</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schroeter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tullius</surname>
<given-names>S. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The potential of senolytics in transplantation</article-title>. <source>Mech. Ageing Dev.</source> <volume>200</volume>, <fpage>111582</fpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2021.111582</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGlynn</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Prina</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Cellular senescence in pretransplant renal biopsies predicts postoperative organ function</article-title>. <source>Aging Cell</source> <volume>8</volume>, <fpage>45</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2008.00447.x</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B. M. W.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vongwiwatana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Urmson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L. F.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Effects of donor age and cell senescence on kidney allograft survival</article-title>. <source>Am. J. Transpl.</source> <volume>9</volume>, <fpage>114</fpage>&#x2013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2008.02500.x</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B. M. W.</given-names>
</name>
<name>
<surname>Vongwiwatana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rayner</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Halloran</surname>
<given-names>P. F.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney</article-title>. <source>Am. J. Transpl.</source> <volume>5</volume>, <fpage>1375</fpage>&#x2013;<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2005.00846.x</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moiseeva</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cisneros</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cobos</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Tarrega</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>O&#xf1;ate</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Perdiguero</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Context-dependent roles of cellular senescence in normal, aged, and disease states</article-title>. <source>FEBS J.</source> <volume>290</volume>, <fpage>1161</fpage>&#x2013;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1111/febs.16573</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morteau</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chakera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Christou</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>P. D.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Renal transplant immunosuppression impairs natural killer cell function <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>PLoS One</source> <volume>5</volume>, <fpage>e13294</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0013294</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu&#xf1;oz-Esp&#xed;n</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cellular senescence: from physiology to pathology</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>15</volume>, <fpage>482</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3823</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mylonas</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Ferenbach</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Targeting senescent cells as therapy for CKD</article-title>. <source>Kidney360</source> <volume>5</volume>, <fpage>142</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.34067/KID.0000000000000316</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mylonas</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>O&#x27;Sullivan</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Docherty</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Neely</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair</article-title>. <source>Sci. Transl. Med.</source> <volume>13</volume>, <fpage>eabb0203</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.abb0203</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oguma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Alessio</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Aprile</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dezawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peluso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Di Bernardo</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics</article-title>. <source>Cell. Commun. Signal.</source> <volume>21</volume>, <fpage>262</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1186/s12964-023-01280-4</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>O. P.</given-names>
</name>
<name>
<surname>Vukmanovic-Stejic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(&#x2b;) T cell inhibition</article-title>. <source>Nat. Commun.</source> <volume>10</volume>, <fpage>2387</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-10335-5</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rex</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Melk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Cellular senescence and kidney aging</article-title>. <source>Clin. Sci. (Lond)</source> <volume>137</volume>, <fpage>1805</fpage>&#x2013;<lpage>1821</lpage>. <pub-id pub-id-type="doi">10.1042/CS20230140</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salminen</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases</article-title>. <source>Ageing Res. Rev.</source> <volume>67</volume>, <fpage>101280</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2021.101280</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindelin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arganda-Carreras</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Frise</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kaynig</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Longair</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pietzsch</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nat. Methods</source> <volume>9</volume>, <fpage>676</fpage>&#x2013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Rasband</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Eliceiri</surname>
<given-names>K. W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>NIH image to ImageJ: 25 years of image analysis</article-title>. <source>Nat. Methods</source> <volume>9</volume>, <fpage>671</fpage>&#x2013;<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schumacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rookmaaker</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Joles</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Kramann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T. Q.</given-names>
</name>
<name>
<surname>van Griensven</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Defining the variety of cell types in developing and adult human kidneys by single-cell RNA sequencing</article-title>. <source>NPJ Regen. Med.</source> <volume>6</volume>, <fpage>45</fpage>&#x2013;<lpage>w</lpage>. <pub-id pub-id-type="doi">10.1038/s41536-021-00156-w</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinning</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Funk</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Soerensen-Zender</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wulfmeyer</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>The aging kidney is characterized by tubuloinflammaging, a phenotype associated with MHC-II gene expression</article-title>. <source>Front. Immunol.</source> <volume>14</volume>, <fpage>1222339</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1222339</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kushida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Moritoki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishijima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohsaki</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Tubular cell senescence in the donated kidney predicts allograft function, but not donor remnant kidney function, in living donor kidney transplantation</article-title>. <source>Am. J. Nephrol.</source> <volume>47</volume>, <fpage>8</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1159/000485845</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincenti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rostaing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grinyo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gaite</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Belatacept and long-term outcomes in kidney transplantation</article-title>. <source>N. Engl. J. Med.</source> <volume>374</volume>, <fpage>333</fpage>&#x2013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1506027</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vondran</surname>
<given-names>F. W. R.</given-names>
</name>
<name>
<surname>Timrott</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kollrich</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Klempnauer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schwinzer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Decreased frequency of peripheral CD4(&#x2b;) CD161(&#x2b;) Th(17) -precursor cells in kidney transplant recipients on long-term therapy with belatacept</article-title>. <source>Transpl. Int.</source> <volume>25</volume>, <fpage>455</fpage>&#x2013;<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-2277.2012.01441.x</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grzywacz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sukovich</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McCullar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A. B.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>The unexpected effect of cyclosporin A on CD56&#x2b;CD16- and CD56&#x2b;CD16&#x2b; natural killer cell subpopulations</article-title>. <source>Blood</source> <volume>110</volume>, <fpage>1530</fpage>&#x2013;<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-10-048173</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wensveen</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Jelen&#x10d;i&#x107;</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Poli&#x107;</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>NKG2D: a master regulator of immune cell responsiveness</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <fpage>441</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00441</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wlaschek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maity</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Makrantonaki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Scharffetter-Kochanek</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Connective tissue and fibroblast senescence in skin aging</article-title>. <source>J. Invest. Dermatol.</source> <volume>141</volume>, <fpage>985</fpage>&#x2013;<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2020.11.010</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates</article-title>. <source>Sci. Transl. Med.</source> <volume>15</volume>, <fpage>eadd1951</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.add1951</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Eddy</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Urokinase and its receptors in chronic kidney disease</article-title>. <source>Front. Biosci.</source> <volume>13</volume>, <fpage>5462</fpage>&#x2013;<lpage>5478</lpage>. <pub-id pub-id-type="doi">10.2741/3093</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>